Despreaux, R., Cohen, S. Y., Semoun, O., Zambrowski, O., Jung, C., Oubraham, H., & Souied, E. H. (2016). Short-term results of switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration in clinical practice. Graefe's archive for clinical and experimental ophthalmology, 254(4), 639-644. https://doi.org/10.1007/s00417-015-3084-1
Chicago-Zitierstil (17. Ausg.)Despreaux, Raphaelle, Salomon Y. Cohen, Oudy Semoun, Olivia Zambrowski, Camille Jung, Hassiba Oubraham, und Eric H. Souied. "Short-term Results of Switchback from Aflibercept to Ranibizumab in Neovascular Age-related Macular Degeneration in Clinical Practice." Graefe's Archive for Clinical and Experimental Ophthalmology 254, no. 4 (2016): 639-644. https://doi.org/10.1007/s00417-015-3084-1.
MLA-Zitierstil (9. Ausg.)Despreaux, Raphaelle, et al. "Short-term Results of Switchback from Aflibercept to Ranibizumab in Neovascular Age-related Macular Degeneration in Clinical Practice." Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 254, no. 4, 2016, pp. 639-644, https://doi.org/10.1007/s00417-015-3084-1.